Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Tae-Hyeok Kim"'
Autor:
Woorim Kim, Tae Hyeok Kim, Soo Jin Oh, Hyun Jeong Kim, Joo Hee Kim, Hyoun-Ah Kim, Ju-Yang Jung, In Ah Choi, Kyung Eun Lee
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Abstract Toll-like receptor (TLR)-4 and TLR9 are known to play important roles in the immune system, and several studies have shown their association with the development of rheumatoid arthritis (RA) and regulation of tumor necrosis factor alpha (TNF
Externí odkaz:
https://doaj.org/article/7559b981ef1d4163b160fee455ec9fe0
Publikováno v:
Asthma Research and Practice, Vol 7, Iss 1, Pp 1-10 (2021)
Abstract Background In March 2020, the US Food and Drug Administration decided that the dangers related to neuropsychiatric events (NPEs) of montelukast, one of the leukotriene modifying agents (LTMAs), should be communicated through ‘boxed warning
Externí odkaz:
https://doaj.org/article/10b1222b5f094d1da44e83dc6ace0a78
Publikováno v:
Journal of the Korea Academia-Industrial cooperation Society. 23:122-131
Autor:
Tae Hyeok Kim, In Ah Choi, Joohee Kim, Hyun Jeong Kim, Woorim Kim, Kyung Eun Lee, Soo Jin Oh, Ju-Yang Jung, Hyoun-Ah Kim
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
Scientific Reports
Scientific Reports
Toll-like receptor (TLR)-4 and TLR9 are known to play important roles in the immune system, and several studies have shown their association with the development of rheumatoid arthritis (RA) and regulation of tumor necrosis factor alpha (TNF-α). How
Publikováno v:
Pharmacopsychiatry. 55(4)
Introduction Various subtypes of severe acute respiratory syndrome coronavirus 2 and variations among immune systems in different ethnicities need to be considered to understand the outcomes of coronavirus disease 2019 (COVID-19). This study aimed to
Autor:
Hyun Jeong Kim, Joohee Kim, Ju-Yang Jung, In Ah Choi, Kyung Eun Lee, Su Jin Oh, Hyoun-Ah Kim, Tae Hyeok Kim, Woorim Kim
Studies that investigate the association between toll-like receptor (TLR)-4 or TLR9 gene polymorphisms and remission from the disease in RA patients taking tumor necrosis factor alpha (TNF-α) inhibitors have yet to be conducted. In this context, thi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0c4adb8a9c34a5772e5edb3e9b7c5362
https://doi.org/10.21203/rs.3.rs-534605/v1
https://doi.org/10.21203/rs.3.rs-534605/v1
Publikováno v:
Asthma Research and Practice
Asthma Research and Practice, Vol 7, Iss 1, Pp 1-10 (2021)
Asthma Research and Practice, Vol 7, Iss 1, Pp 1-10 (2021)
Background In March 2020, the US Food and Drug Administration decided that the dangers related to neuropsychiatric events (NPEs) of montelukast, one of the leukotriene modifying agents (LTMAs), should be communicated through ‘boxed warning’. In c